trial with title AEYE-DS-001_Diabetic Retonpathy

Are you a Diabetic?

Consider Participating in a Clinical Trial

If you are a diabetic and have NOT been previously diagnosed with Diabetic Retinopathy, than you may be eligible to participate in a clinical trial.


ONLINE Pre-Screener Disclaimer:

If you meet the initial criteria listed for this trial, please take the prescreening questionnaire below to see if you might qualify to participate in this study. If you pass the pre-screener you will have the opportunity to search and provide your contact information to a study site so that you can discuss the study with the study site and arrange for a screening visit, if applicable.

If you choose to proceed, all response data, regardless of your eligibility, will be stored in a database in the United States in a de-identified manner (the response data is not tied to you as an individual) for analytics purposes.

Conducted by

Logo

Study Summary

AEYE-DS is a software device developed to increase compliance with diabetic retinopathy screening by automatically detecting more-than-mild diabetic retinopathy from digital fundus images using AI-based software. This study has been designed to validate the safety and efficacy of the device at primary care and other point of care sites.


Eligible study participants will receive expert screening for Diabetic Retinopathy, and a $50 stipend. 

See If You Are Eligible

Inclusion Criteria:
  • Age 22 or older
  • Male or female
  • Documented diagnosis of diabetes mellitus
  • Understand the study and volunteer to sign the informed consent

Additional Information

  • Condition: Diabetic Retinopathy, Diabetic Retinopathy, Diabetic Macular Edema, Diabetes Prevention, Diabetic Macular Edema, Diabetes Mellitus Types I and II, Diabetes (Pediatric)
  • Gender: Both
  • Age: 22-100
  • Phase: N/A
  • Status: Not Recruiting
  • Start Date: 10/16/2020
  • End Date: 04/15/2021
  • Last Updated: 05/05/2021